Literature DB >> 12040889

Role of subcortical structures in the pathogenesis of infantile spasms: what are possible subcortical mediators?

F A Lado1, S L Moshé.   

Abstract

Infantile spasms present a constellation of symptoms and laboratory findings that suggest a role of subcortical circuits in the pathogenesis of this illness. The clinical features of spasms and the influence of subcortical circuits in the regulation of the electroencephologram, along with frequent abnormalities in subcortical structure and functional anatomy, brain stem electrophysiology, sleep regulation, and subcortical neurotransmitter levels, point to the importance of subcortical circuits in the generation of spasms. Furthermore, laboratory evidence shows that modulation of subcortical nuclei may attenuate and ameliorate seizures. We review clinical evidence indicating abnormal function in subcortical circuits and present a hypothesis that the development of infantile spasms requires dysfunction in both cortical and subcortical circuits. The confluence of evidence suggesting a role of subcortical structures in the origin of spasms and laboratory data indicating an anticonvulsant role on some subcortical nuclei raise the possibility of novel approaches to the treatment of infantile spasms.

Entities:  

Mesh:

Year:  2002        PMID: 12040889     DOI: 10.1016/s0074-7742(02)49010-1

Source DB:  PubMed          Journal:  Int Rev Neurobiol        ISSN: 0074-7742            Impact factor:   3.230


  24 in total

1.  Early Anatomical Injury Patterns Predict Epilepsy in Head Cooled Neonates With Hypoxic-Ischemic Encephalopathy.

Authors:  Da Eun Jung; David G Ritacco; Douglas R Nordli; Sookyong Koh; Charu Venkatesan
Journal:  Pediatr Neurol       Date:  2015-04-24       Impact factor: 3.372

Review 2.  Inflammation in Epileptic Encephalopathies.

Authors:  Oleksii Shandra; Solomon L Moshé; Aristea S Galanopoulou
Journal:  Adv Protein Chem Struct Biol       Date:  2017-02-28       Impact factor: 3.507

Review 3.  Mechanisms of epileptogenesis in pediatric epileptic syndromes: Rasmussen encephalitis, infantile spasms, and febrile infection-related epilepsy syndrome (FIRES).

Authors:  Carlos A Pardo; Rima Nabbout; Aristea S Galanopoulou
Journal:  Neurotherapeutics       Date:  2014-04       Impact factor: 7.620

4.  High frequency EEG activity associated with ictal events in an animal model of infantile spasms.

Authors:  James D Frost; Chong L Lee; Richard A Hrachovy; John W Swann
Journal:  Epilepsia       Date:  2011-01-04       Impact factor: 5.864

Review 5.  Pathogenesis and new candidate treatments for infantile spasms and early life epileptic encephalopathies: A view from preclinical studies.

Authors:  Aristea S Galanopoulou; Solomon L Moshé
Journal:  Neurobiol Dis       Date:  2015-05-09       Impact factor: 5.996

6.  Epilepsy surgery in pediatric epileptic encephalopathy: when interictal EEG counts the most.

Authors:  Amre Shahwan; Philip J O'Halloran; Cathy Madigan; Mary D King; Donncha O'Brien
Journal:  Childs Nerv Syst       Date:  2016-05-14       Impact factor: 1.475

7.  MRI findings in infants with infantile spasms after neonatal hypoxic-ischemic encephalopathy.

Authors:  Dawn Gano; Michael A Sargent; Steven P Miller; Mary B Connolly; Peter Wong; Hannah C Glass; Kenneth J Poskitt; Vann Chau
Journal:  Pediatr Neurol       Date:  2013-10-02       Impact factor: 3.372

Review 8.  Pathophysiology of epileptic encephalopathies.

Authors:  Fred A Lado; Guido Rubboli; Giuseppe Capovilla; Pippo Capovilla; Giuliano Avanzini; Solomon L Moshé
Journal:  Epilepsia       Date:  2013-11       Impact factor: 5.864

9.  A model of symptomatic infantile spasms syndrome.

Authors:  Morris H Scantlebury; Aristea S Galanopoulou; Lenka Chudomelova; Emmanuel Raffo; David Betancourth; Solomon L Moshé
Journal:  Neurobiol Dis       Date:  2009-11-26       Impact factor: 5.996

Review 10.  Basic mechanisms of catastrophic epilepsy -- overview from animal models.

Authors:  Aristea S Galanopoulou
Journal:  Brain Dev       Date:  2013-01-11       Impact factor: 1.961

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.